1. Introduction {#sec1-molecules-23-03128}
===============

Chinese medicine processing and Chinese medicinal formula compatibility are two outstanding characteristics in the clinical applications of Chinese medicine. However, current studies often focus on the compatibility mechanism or processing mechanism alone without combining them together organically, and reports discussing Chinese medicine processing mechanisms in Chinese medicinal formulae have been rarely involved. Therefore, the selection of the processed products of Chinese herbal medicines contained in Chinese medicinal formulae has only to rely on the experiences of clinicians without sufficient basis of scientific theories.

Sinisan (SNS), an ancient well-known Chinese medicinal formula consisting of four Chinese herbal medicines---Bupleuri Radix (BR), Paeoniae Radix Alba (PRA), Aurantii Fructus Immaturus (AFI), and Glycyrrhizae Radix et Rhizoma Praeparata Cum Melle (GRM), has been regarded as an effective anti-depression prescription according to the traditional Chinese medicine (TCM) theories of six channels and depression. SNS was initially described by Zhongjing Zhang in 'Treatise on Febrile Diseases' as a traditional Chinese herbal formula to cure mental disorders. It has been widely used for thousands of years, and even today it is still the fundamental and essential prescription for the treatment of depression \[[@B1-molecules-23-03128],[@B2-molecules-23-03128]\]. However, the application of processed BR and processed PRA contained in SNS is quite controversial, which is necessary to improve our understanding whether the processing procedures has changed any chemical constituents of the herbal medicine.

At present, ultra-high performance liquid chromatography coupled with electrospray ionization tandem quadrupole/time of flight mass spectrometry (UHPLC-Q-TOF/MS) is a powerful tool for the analysis of complex samples in TCM and possesses high resolution, efficiency, and sensitivity to obtain accurate mass information \[[@B3-molecules-23-03128],[@B4-molecules-23-03128],[@B5-molecules-23-03128],[@B6-molecules-23-03128]\]. Multivariate statistical analysis based on all the available chemical information has made the identification of potential chemical markers possible. In this report, we successfully developed an UHPLC-Q-TOF/MS method coupled with multiple statistical strategy to analyze the compound profiles of SNS.

Based on the theory of TCM, processing with vinegar can enhance the effects of coursing liver and resolving depression \[[@B7-molecules-23-03128]\]. A previous report has suggested that vinegar-processed BR (VPBR) is more effective in the treatment of liver disorders, including hepatitis, cirrhosis, and liver cancer \[[@B8-molecules-23-03128]\]. In this study, we creatively analyzed the compound profiles of individual herb, herb-pair, and complicated Chinese herbal formula according to their representative herbal medicine: BR, PRA, BR-PRA herb-pair, and SNS, respectively, and also systematically compared the changes of chemical constituents of BR, PRA, BR-PRA herb-pair, and SNS before and after processing to reveal the scientific connotation of processing and formula compatibility. We are looking forward to seeking out the common mechanism of processing and formula compatibility of Chinese herbal medicine in order to provide scientific theory for safe clinical applications of Chinese medicine and rational herbal medicine processing in Chinese medicinal formula.

2. Results and Discussion {#sec2-molecules-23-03128}
=========================

2.1. Identification of Compounds {#sec2dot1-molecules-23-03128}
--------------------------------

According to the previous reports \[[@B9-molecules-23-03128],[@B10-molecules-23-03128],[@B11-molecules-23-03128],[@B12-molecules-23-03128]\], saponins, terpenoids, and flavones are the main chemical components in BR (VPBR), PRA (VPPRA), AFI, and GRM. These components easily lose a proton under mass spectrum detection, resulting in a better mass response in negative ion mode than in positive one. As shown in [Table 1](#molecules-23-03128-t001){ref-type="table"}, 101 compounds were identified in negative ion mode and 21 compounds were identified in positive ion mode \[[@B13-molecules-23-03128],[@B14-molecules-23-03128],[@B15-molecules-23-03128]\]. The typical total ion chromatograms (TICs) of BR, VPBR, PRA, vinegar-processed PRA (VPPRA), BR-PRA herb-pair, VPBR-VPPRA herb-pair, SNS, and SNS-containing VPBR and VPPRA in both ion modes are shown in [Figure 1](#molecules-23-03128-f001){ref-type="fig"}.

2.2. Multivariate Data Analysis {#sec2dot2-molecules-23-03128}
-------------------------------

Using MarkerView^TM^ 1.2.1 data handling software, multivariate data analysis were completed. The principal component analysis (PCA) score plot in negative and positive ion modes were shown in [Figure 2](#molecules-23-03128-f002){ref-type="fig"}. The results showed that all crude and processed samples including individual herb, herb-pair, and complicated Chinese medicinal formula were successfully classified into two categories in both positive and negative ion modes.

2.3. Compounds Changed after Processing and Formula Compatibility {#sec2dot3-molecules-23-03128}
-----------------------------------------------------------------

The variations of components (*p* \< 0.05) in the individual herb, herb-pair, and complicated Chinese herbal formula before and after processing were shown in [Table 2](#molecules-23-03128-t002){ref-type="table"} and [Table 3](#molecules-23-03128-t003){ref-type="table"}. For BR, 22 peaks were shown significant differences after processing. Comparing with BR, the intensity of seven peaks increased in VPBR; the other 15 peaks declined in VPBR. Taking compatibility into consideration, it was interesting to find that 14 peaks contributing to differentiate crude and processed individual herbs disappeared in herb-pair, while three new peaks (isorhamnetin-3-rutinoside, HOSSd, 2′′-*O*-AcetylSSd) appeared. Additionally, prosaikogenin f decreased in individual herb but increased in herb-pair. Compatibility may be responsible for these changes. On the contrary, adonltol, SSh, SSi, SSg, SSb~1~, 3′′-*O*-AcetylSSa, and SSd all showed the same trend after processing of BR in the individual herb and herb-pair. Thus, it was hard to distinguish that the seven components were affected by processing, compatibility, or even their combination. Taking into further account the formula compatibility effect of AFI and GRM, eight peaks showing significant differences in herb-pair vanished in the formula, however seven new peaks (isorhamnetin, buddlejasaponin IV, acetylSSc, 4′′-*O*-AcetylSSa, SSe, 6′′-*O*-AcetylSSa, and 6′′-*O*-AcetylSSd) appeared. Meanwhile SSg, 3′′-*O*-AcetylSSa, and SSd showed the same tendency and this would result in the unidentifiable problem.

For PRA, 20 peaks showed significant differences after processing. Comparing with PRA, the intensity of 13 peaks enhanced in VPPRA, the other seven peaks decreased in VPPRA. Considering compatibility, 10 of these 20 peaks disappeared in the herb-pair, at the same time, 6-*O*-β-[d]{.smallcaps}-glucopyranosyl lactinolide and benzoylpaeoniflorin appeared. Also, cianidanol enhanced in individual herb but decreased in herb-pair. These changes perhaps resulted from compatibility. Moreover, nine peaks had the same trend after processing of PRA in individual herb and herb-pair, and it was also hard to distinguish as BR. Under further influence of formula compatibility with AFI and GRM, five peaks showing significant differences in herb-pair vanished in formula; oppositely, five new peaks (oxypaeoniflora, 6′-*O*-β-[d]{.smallcaps}-glucopyranosylalbiflorin, galloylpaeoniflorin, lactiflorin, benzoylalbiflorin) appeared. Formula compatibility may be responsible for these changes. In addition, seven peaks (6-*O*-β-[d]{.smallcaps}-glucopyranosyl lactinolide, mudanpioside f, albiflorin, isomaltoalbiflorin, paeoniflorigenone, paeonol, and benzoic acid) displayed an identical trend; this still led to the unidentifiable problem. [Figure 3](#molecules-23-03128-f003){ref-type="fig"} shows the comparison of the contents of the components identified with significant differences. Processing with vinegar and formula compatibility can both regulate the acidity and alkalinity of the solution and promote changes in chemical composition, such as hydrolysis reaction, isomerization reaction, etc., resulting in increased or decreased dissolution of some components. Finally, we found that processing of BR and PRA also had the impact on AFI and GRM, and the results were shown in [Table 4](#molecules-23-03128-t004){ref-type="table"}.

As shown in [Table 2](#molecules-23-03128-t002){ref-type="table"}, the intensity of paeonol significantly increased after stir-frying with vinegar. According to a previous report \[[@B16-molecules-23-03128]\], adding acid could greatly improve the extraction efficiency of paeonol. Since the boiling point of paeonol is 154 °C, the use of slow fire (130 °C) controlled by infrared radiation thermometer during the processing minimized the loss of paeonol. In addition, acetic acid plays an important role to form intermolecular hydrogen bonds by Van der Waals' force with paeonol, resulting in the increase of dissolution rate. Modern researches indicate that paeonol has analgesic and antiphlogistic pharmacological activities \[[@B17-molecules-23-03128],[@B18-molecules-23-03128]\] and is consistent with TCM theory that processing of medicinal herbs with vinegar can enhance the effects of promoting blood circulation and relieving pain. As an illustration, [Figure 4](#molecules-23-03128-f004){ref-type="fig"} revealed the course of deducing fragmentation of paeonol.

As shown in [Table 3](#molecules-23-03128-t003){ref-type="table"}, we found that the intensity of SSa and SSd declined but the intensity of SSb~2~ and SSb~1~ increased in the BR. SSs, a kind of oleanane type triterpenoid saponin, could be divided into seven types according to their different aglycones. SSa, SSd, and SSc are epoxy-ether saikosaponins (type I), while SSb~2~ and SSb~1~ with a different aglycone, form a heterocyclic diene saikosaponin (type II) \[[@B19-molecules-23-03128]\]. The glycosidic bond is very easily hydrolyzed in the acidic conditions or being heated \[[@B20-molecules-23-03128],[@B21-molecules-23-03128]\]. Vinegar processing could promote the hydrolyzation from 13 to 28 allyl oxide linkage to its corresponding heteroannular diene structure, resulting in the aglycone accumulation. As shown in [Figure 5](#molecules-23-03128-f005){ref-type="fig"}, peak No. 94 was clearly observed in VPBR, VPBR-VPPRA herb-pair, SNS-containing VPBR and VPPRA, and SNS, and almost undetectable in BR and BR-PRA herb-pair. According to the fragmentations in both positive and negative ion modes and other reports \[[@B22-molecules-23-03128],[@B23-molecules-23-03128],[@B24-molecules-23-03128]\], we suggested that peak No. 94 is SSg. SSg in SNS could be related to the acidic compounds of herbal formula, such as glycyrrhizic acid. Also, peak No. 68 (SSh/i), as the isomer of SSc, had the same change with SSg. Based on these, we hypothesized that SSa and SSd could be transformed to SSb~2~, SSb~1~, and SSg, while SSc could be converted to SSh and SSi after processing and formula compatibility.

3. Materials and Methods {#sec3-molecules-23-03128}
========================

3.1. Materials and Reagents {#sec3dot1-molecules-23-03128}
---------------------------

Acetonitrile (Merck, Darmstadt, Germany) and formic acid from Anaqua Chemical Supply (ACS, Houston, TX, USA) of HPLC/MS-grade were purchased for UHPLC-Q-TOF/MS analysis. Deionized water was prepared using a Milli-Q system (Millipore, Molsheim, France). SPE columns (LC-C~18~, 500 mg/mL) were purchased from ANPLE Scientific Instrument (Shanghai, China). Other reagents of analytical grade were purchased from Nanjing Chemical Reagent Co., Ltd. (Jiangsu, China).

BR, PRA, AFI, and GRM were obtained from different Chinese pharmacies and pharmaceutical factories, and authenticated by Professor Hao Cai. The quality of all collected samples was strictly evaluated and consistent with the regulations of Chinese Pharmacopoeia (Edition 2015, Part One). VPBR and VPPRA were prepared according to the processing standards described in Chinese Pharmacopoeia (Edition 2015, Part Four). The voucher specimens were deposited in School of Pharmacy, Nanjing University of Chinese Medicine (Nanjing, China).

3.2. Sample Preparation {#sec3dot2-molecules-23-03128}
-----------------------

The decoction of BR was prepared as follows. Eight grams of BR were extracted twice in a reflux water heating mantle in 48 mL and 32 mL of deionized water for 1.5 h and 1 h of reflux, respectively. The mixed solution was filtered through a four-layer mesh following the reflux. One milliliter of the solution was loaded onto a C~18~ RP SPE column and the gradient elution was performed as the following sequence. One milliliter of 20% acetonitrile in water (20:80, *v*/*v*), 1 mL of 40% acetonitrile in water (40:60, *v*/*v*), 1 mL of 60% acetonitrile in water (60:40, *v*/*v*), 1 mL of 80% acetonitrile in water (80:20, *v*/*v*), and 1 mL of acetonitrile. After the sequent elution, the collected eluent was eddied for 2 min and centrifuged at 13,000 rpm for 5 min. Finally, the supernatant was collected as the injection solution. The decoctions of VPBR, PRA, and VPPRA were prepared according to the same procedures above.

The decoction of BR-PRA herb-pair consisted of 4 g of BR and 4 g of PRA, and prepared as the same procedures as individual herb described above. The decoction of VPBR-VPPRA herb-pair was prepared using the same procedures as the decoction of BR-PRA herb-pair. The decoction of SNS was consist of 2 g of BR, 2 g of PRA, 2 g of AFI, and 2 g of GRM, and prepared using the same procedures as individual herb. The decoction of SNS containing VPBR and VPPRA was prepared using the same procedures as the decoction of SNS.

3.3. Chromatographic Separation {#sec3dot3-molecules-23-03128}
-------------------------------

Chromatographic analysis was performed using a UHPLC system (Shimadzu, Kyoto, Japan) consisting of an LC-30AD binary pump, an autosampler (Model SIL-30SD), an online degasser (DGU-20A5R), and a temperature controller for columns (CTO-30A). Separation was carried out on an extended C~18~ Column (2.1 mm × 100 mm, 1.8 μm; Agilent, Palo Alto, CA, USA) at 30 °C and the flow rate was 0.3 mL/min. The optimal mobile phase consisted of A (HCOOH/H~2~O, 0.1:100, *v*/*v*) and B (C~2~H~3~N). The optimized UHPLC elution conditions were as follows 0--2 min, 3--15% B; 2--7 min, 15--20% B;7--8 min, 20% B; 8--9 min, 20--30% B; 9--13 min, 30--32% B; 13--21 min; 32--54% B; 21--23 min, 54--100% B; 23--27 min, 100--3% B; and 27--28 min, 3% B. The injection volume was 2 μL.

3.4. MS and MS/MS Experiments {#sec3dot4-molecules-23-03128}
-----------------------------

A triple TOF 5600^+^ System (AB Sciex, Concord, CA, USA) equipped with an electrospray ionization (ESI) source was performed. The MS was operated in both positive and negative ion modes. Parameters were set as follows: ion spray voltage of +4500/−4500 V; turbo spray temperature of 550 °C; declustering potential (DP) of +60/−60 V; collision energy of +35/−45 V; nebulizer gas (gas 1) of 55 psi; heater gas (gas 2) of 55 psi and curtain gas of 35 psi. TOF MS and TOF MS/MS were scanned with the mass ranges of *m*/*z* 100--2000 and 50--1000, respectively. The experiments were run with 200 ms accumulation time for TOF MS and 80 ms accumulation time for TOF MS/MS. Continuous recalibration was performed at the intervals of 3 h. Dynamic background subtraction and information-dependent acquisition techniques were applied to reduce the impact of matrix interference and increase the efficiency of analysis.

3.5. MS and MS/MS Data Processing and Analysis {#sec3dot5-molecules-23-03128}
----------------------------------------------

The raw data were obtained by the Analyst TF 1.6 software (AB Sciex, Concord, CA, USA). Before data processing, a database about chemical components of medicinal herbs in SNS, including names, molecular formulas, chemical structures, and accurate molecular weights, was established by searching relevant reported literature and database websites, including PubMed and SciFinder. The data were analyzed by using PeakView^TM^ 1.2 software (AB Sciex, Concord, CA, USA) for a perfect match with the information in the established database, according to fragmentations of the different peaks. The main parameters used were set as follows: retention time range of 0--28 min, mass range of 100 to 2000 Da, and mass tolerance of 10 ppm. By using the method of PCA with MarkerView^TM^ 1.2.1 software (AB Sciex, Concord, CA, USA) to check for outliers and variation trend, the gathered data were more intuitionistic. The Student's *t*-test was performed to find out a list of peaks that were finally defined as the main contributors to the significant difference between raw and processed medicinal herbs (*p* \< 0.05).

4. Conclusions {#sec4-molecules-23-03128}
==============

A total of 122 constituents had been identified by creative global analysis in individual herb, herb-pair, and complicated Chinese herbal formula of SNS. Taking BR as an example, 29 kinds of SSs had been identified, including some new discoveries in recent years, such as SSq, SSm, and so forth. Monoterpene glycosides (oxypaeoniflora, mudanpioside f, paeoniflorigenone, etc) showed a marked increase after processing of PRA. This is the first report of SSh/i and SSg being identified in SNS. Through three progressive levels of comparison, it suggests that processing herbal medicine and/or changing medicinal formula compatibility could alter herbal chemical constituents, resulting in different pharmaceutical effects. Herbal formula has always been the predicament of Chinese medicine research, and some scholars only employed SSd and paeoniflorin (the main components of BR and PRA) for research \[[@B25-molecules-23-03128]\], whereas the effects between individual components and herbal formula containing individual components are quite different. We hope that the thoughts of this article would be some helpful for further research of herbal formula.

**Sample Availability:** Samples of Bupleuri Radix, Paeoniae Radix Alba, Aurantii Fructus Immaturus, and Glycyrrhizae Radix et Rhizoma Praeparata Cum Melle are available from the authors.
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GRM

Glycyrrhizae Radix et Rhizoma Praeparata Cum Melle

PRA

Paeoniae Radix Alba; SNS, Sinisan

SS
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TCM

traditional Chinese medicine

UHPLC-Q-TOF/MS

ultrahigh performance liquid chromatography coupled with electrospray ionization tandem quadrupole-time-of-flight mass spectrometry

VPBR

vinegar-processed Bupleuri Radix

VPPRA

vinegar-processed Paeoniae Radix Alba

PCA

principal component analysis

![Typical total ion chromatograms (TICs) in positive ion mode of PRA (**A**), VPPRA (**I**), BR (**C**), VPBR (**K**), BR-PRA herb-pair (**E**), VPBR-VPPRA herb-pair (**M**), SNS (**G**), and SNS-containing VPBR and VPPRA (**O**). Typical total ion chromatograms (TICs) in negative ion mode of PRA (**B**), VPPRA (**J**), BR (**D**), VPBR (**L**), BR-PRA herb-pair (**F**), VPBR-VPPRA herb-pair (**N**), SNS (**H**), and SNS-containing VPBR and VPPRA (**P**).](molecules-23-03128-g001){#molecules-23-03128-f001}

![Principal component analysis (PCA) score plots in positive ion mode of PRA and VPPRA (**A**), BR and VPBR (**C**), BR-PRA herb-pair and VPBR-VPPRA herb-pair (**E**), SNS and SNS containing VPBR and VPPRA (**G**). PCA score plots in negative ion mode of PRA and VPPRA (**B**), BR and VPBR (**D**), BR-PRA herb-pair and VPBR-VPPRA herb-pair (**F**), and SNS and SNS-containing VPBR and VPPRA (**H**).](molecules-23-03128-g002){#molecules-23-03128-f002}

![Contents of components identified with significant differences in individual herb, herb-pair, and complicated Chinese herbal formula of SNS.](molecules-23-03128-g003){#molecules-23-03128-f003}

![MS and tandem mass spectroscopy (MS/MS) spectra and fragmentation of Paeonol.](molecules-23-03128-g004){#molecules-23-03128-f004}

![Comparison on intensity of five isomers of Saikosaponins in BR, BR-PRA herb-pair, and SNS (**B**). Comparison on intensity of five isomers of Saikosaponins in VPBR, VPBR-VPPRA herb-pair, and SNS-containing VPBR and VPPRA (**A**).](molecules-23-03128-g005){#molecules-23-03128-f005}
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###### 

Identification of chemical compounds by ultrahigh performance liquid chromatography coupled with electrospray ionization tandem quadrupole-time-of-flight mass spectrometry (UHPLC-Q-TOF-MS/MS).

  No.   Compound                                                T~R~ (min)   Molecular Formula   Detected Mass (*m*/*z*) Ion Type   Mass Error (ppm)   MS/MS *(m*/*z*)                Purity Score   Source
  ----- ------------------------------------------------------- ------------ ------------------- ---------------------------------- ------------------ ------------------------------ -------------- --------
  1     Adonitol                                                0.82         C~5~H~12~O~5~       151.0612 \[M − H\]^−^              4.0                101.0283,83.0141,71.0171       88.30%         BR
  2     Sucrose                                                 0.83         C~12~H~22~O~11~     387.1133 \[M + HCOOH-H\]^−^        1.0                341.1099,161.0458,89.0264      100.00%        PRA
  3     Synephrine                                              1.22         C~9~H~13~NO~2~      168.1019 \[M + H\]^+^              −2.4               150.0912,121.0653,91.0553      76.20%         AFI
  4     Gallic acid                                             1.97         C~7~H~6~O~5~        169.0142 \[M − H\]^−^              2.4                125.0246,79.0210,51.0283       79.40%         PRA
  5     1-*O*-β-[d]{.smallcaps}-glucopyranosyl-paeonisuffrone   2.39         C~16~H~24~O~9~      405.1391 \[M + HCOOH-H\]^−^        1.3                197.0814,137.0603,85.0304      83.90%         PRA
  6     6-*O*-β-[d]{.smallcaps}-glucopyranosyl lactinolide      3.16         C~16~H~26~O~9~      407.1547 \[M + HCOOH-H\]^−^        1.4                361.1514,199.0974,101.0250     100.00%        PRA
  7     Mudanpioside f                                          3.31         C~16~H~24~O~8~      389.1442 \[M + HCOOH-H\]^−^        0.9                181.0835,151.0767,109.0646     88.10%         PRA
  8     Neochlorogenic acid                                     3.48         C~16~H~18~O~9~      353.0884 \[M − H\]^−^              1.6                191.0555, 135.0449, 85.0305    93.90%         BR
  9     Oxypaeoniflora                                          3.83         C~23~H~28~O~12~     495.1508 \[M − H\]^−^              −0.9               495.1560,137.0238              100.00%        PRA
  10    4′′-Hydroxy-3′′-methoxyalbiflorin                       4.16         C~24~H~30~O~13~     571.1658 \[M + HCOOH-H\]^−^        −2.0               525.1653,363.1080,167.0345     100.00%        PRA
  11    Chlorogenic acid                                        4.18         C~16~H~18~O~9~      353.0878 \[M − H\]^−^              0.9                191.0558,85.0300               100.00%        BR
  12    Cryptochlorogenic acid                                  4.35         C~16~H~18~O~9~      353.0888 \[M − H\]^−^              2.7                191.0554, 155.0330, 93.0353    93.50%         BR
  13    Cianidanol                                              4.40         C~15~H~14~O~6~      289.0718 \[M − H\]^−^              2.0                245.0824,137.0238,109.0294     81.10%         PRA
  14    Fabiatrin                                               4.52         C~21~H~26~O~13~     531.1345 \[M + HCOOH-H\]^−^        2.3                177.0189                       100.00%        AFI
  15    6′-*O*-β-[d]{.smallcaps}-glucopyranosylalbiflorin       4.76         C~29~H~38~O~16~     687.2131 \[M + HCOOH-H\]^−^        −8.7               641.2078,489.1612,183.0668     100.00%        PRA
  16    5,7-dihydroxycoumarin                                   4.99         C~9~H~6~O~4~        177.0193 \[M − H\]^−^              6.3                177.0205,69.0003               72.80%         AFI
  17    Lonicerin                                               5.03         C~27~H~30~O~15~     593.1512 \[M − H\]^−^              −0.7               593.1543,353.0670,297.0776     100.00%        AFI
  18    Isomaltopaeoniflorin                                    5.13         C~29~H~38~O~16~     687.2131 \[M + HCOOH-H\]^−^        0.2                611.2036,323.0995,165.0563     100.00%        PRA
  19    Albiflorin                                              5.49         C~23~H~28~O~11~     481.1704 \[M + H\]^+^              1.0                319.1183,133.0645,105.0334     100.00%        PRA
  20    Paeoniflorigenone                                       5.58         C~17~H~18~O~6~      319.1176 \[M + H\]^+^              2.5                151.0757,105.0349,77.0406      100.00%        PRA
  21    Isomaltoalbiflorin                                      5.61         C~29~H~38~O~16~     687.2131 \[M + HCOOH-H\]^−^        −9.1               641.2088,491.1763              100.00%        PRA
  22    Schaftoside                                             5.91         C~26~H~28~O~14~     563.1406 \[M − H\]^−^              1.0                563.1478,443.1016,365.0682     100.00%        GRM
  23    Paeoniflorin                                            5.98         C~23~H~28~O~11~     525.1603 \[M + HCOOH-H\]^−^        5.3                449.1492,165.0558,121.0301     100.00%        PRA
  24    Paeonol                                                 6.70         C~9~H~10~O~3~       165.0557 \[M − H\]^−^              1.8                119.0507,96.9579               100.00%        PRA
  25    Ethyl gallate                                           6.90         C~9~H~10~O~5~       197.0456 \[M − H\]^−^              2.5                162.8362,89.0271,59.0154       100.00%        PRA
  26    SSq                                                     7.32         C~54~H~88~O~24~     1165.5639 \[M + HCOOH-H\]^−^       0.2                1119.5784, 1089.5630           91.00%         BR
  27    Rutin                                                   7.57         C~27~H~30~O~16~     611.1607 \[M + H\]^+^              −1.4               303.0506                       100.00%        BR
  28    liquiritin apioside                                     7.75         C~26~H~30~O~13~     549.1614 \[M − H\]^−^              1.2                549.1659,255.0666,135.0088     100.00%        GRM
  29    Liquiritin                                              7.93         C~21~H~22~O~9~      417.1191 \[M − H\]^−^              0.5                255.0667,135.0090              100.00%        GRM
  30    Neoeriocitrin                                           8.18         C~27~H~32~O~15~     595.1668 \[M − H\]^−^              0.8                595.1719,287.0566,135.0449     100.00%        AFI
  31    Scopoletin                                              9.04         C~10~H~8~O~4~       237.0394 \[M + HCOOH-H\]^−^        6.7                121.0295,93.0328,71.0160       100.00%        AFI
  32    Kaempferol                                              9.19         C~15~H~10~O~6~      287.0550 \[M + H\]^+^              −0.7               287.0533,93.0374               100.00%        BR
  33    SSv                                                     9.47         C~53~H~86~O~24~     1151.5480 \[M + HCOOH-H\]^−^       −3.1               1105.5579,791.4285,313.1119    95.90%         BR
  34    Narirutin                                               9.50         C~27~H~32~O~14~     579.1719 \[M − H\]^−^              2.9                271.0622,151.0033              100.00%        AFI
  35    Isorhamnetin                                            9.56         C~16~H~12~O~7~      317.0656 \[M + H\]^+^              0.2                317.0648,257.0430              73.60%         BR
  36    Isorhamnetin-3-rutinoside                               9.65         C~28~H~32~O~16~     623.1618 \[M − H\]^−^              −0.1               623.1665,315.0513,299.0196     75.50%         BR
  37    Isochlorogenic acid b                                   9.68         C~25~H~24~O~12~     561.1239 \[M + HCOOH-H\]^−^        0.3                385.0916,193.0504,147.0257     83.60%         BR
  38    Naringin                                                10.07        C~27~H~32~O~14~     579.1719 \[M − H\]^−^              0.9                579.1771,271.0614,151.0032     100.00%        AFI
  39    Benzoic acid                                            10.08        C~7~H~6~O~2~        123.0441 \[M + H\]^+^              −5.6               105.0358,77.0394               90.50%         PRA
  40    Isorhamnetin-3-glucoside                                10.11        C~22~H~22~O~12~     479.1184 \[M + H\]^+^              −2.0               317.0667                       89.10%         BR
  41    Mudanpioside i                                          10.18        C~23~H~28~O~11~     479.1559 \[M − H\]^−^              −1.5               121.0302,77.0416               100.00%        PRA
  42    Galloylpaeoniflorin                                     10.19        C~23~H~28~O~10~     509.1654 \[M + HCOOH-H\]^−^        1.1                121.0302,77.0415               100.00%        PRA
  43    Neohesperidin                                           10.23        C~28~H~34~O~15~     609.1825 \[M − H\]^−^              1.4                325.0730,301.0726              70.40%         AFI
  44    Hesperetin                                              10.39        C~16~H~14~O~6~      303.0863 \[M + H\]^+^              1.4                303.0872,153.0181,67.0204      100.00%        AFI
  45    Hesperidin                                              10.40        C~28~H~34~O~15~     609.1825 \[M − H\]^−^              0.8                609.1887,301.0725,283.0621     72.60%         AFI
  46    Isoliquiritin apioside                                  10.56        C~26~H~30~O~13~     549.1614 \[M − H\]^−^              2.3                549.1667,255.0663,135.0082     100.00%        GRM
  47    Isochlorogenic acid a                                   10.61        C~25~H~24~O~12~     561.1239 \[M + HCOOH-H\]^−^        −0.9               323.0849,193.0482,147.0296     82.60%         BR
  48    Lactiflorin                                             10.68        C~23~H~26~O~10~     480.1864 \[M + NH4\]^+^            0.5                301.1076,151.0752,105.0343     100.00%        PRA
  49    Ononin                                                  10.83        C~22~H~22~O~9~      431.1337 \[M + H\]^+^              1.1                269.0807                       100.00%        GRM
  50    Rhoifolin                                               10.94        C~27~H~30~O~14~     577.1563 \[M − H\]^−^              −0.9               271.0613,151.0030              100.00%        AFI
  51    Isochlorogenic acid c                                   11.06        C~25~H~24~O~12~     561.1239 \[M + HCOOH-H\]^−^        0.2                323.0766,193.0494,147.0452     75.70%         BR
  52    Clinoposaponin XII                                      11.19        C~42~H~68~O~14~     795.4536 \[M − H\]^−^              −0.4               795.4661,633.4072,471.3084     100.00%        BR
  53    epinortrachelogenin                                     11.86        C~20~H~22~O~7~      373.1293 \[M − H\]^−^              0.3                179.0711,99.0091               70.90%         BR
  54    Heraclenin                                              11.93        C~16~H~14~O~5~      287.0914 \[M + H\]^+^              0.9                287.0906,153.0176,133.0640     100.00%        AFI
  55    Liquiritigenin                                          11.98        C~15~H~12~O~4~      255.0663 \[M − H\]^−^              2.6                135.0082,119.0505,91.0195      100.00%        GRM
  56    HOSSa                                                   12.17        C~42~H~70~O~14~     797.4693 \[M − H\]^−^              −1.9               635.4196                       100.00%        BR
  57    Puerarin                                                12.29        C~21~H~20~O~9~      417.1180 \[M + H\]^+^              −0.2               417.1094,367.0811,131.0498     77.70%         BR
  58    5,4′′-dihydroxy-3,7-dimethoxyflavone                    12.65        C~17~H~14~O~6~      315.0863 \[M + H\]^+^              0.2                315.0856,243.0647,175.0386     72.50%         GRM
  59    HOSSd                                                   12.79        C~42~H~70~O~14~     797.4693 \[M − H\]^−^              −0.9               635.4235                       100.00%        BR
  60    Buddlejasaponin IV                                      13.24        C~48~H~78~O~18~     987.5159 \[M + HCOOH-H\]^−^        0.3                941.5229,795.4616              100.00%        BR
  61    Clinoposaponin XIV                                      13.45        C~42~H~68~O~14~     795.4536 \[M − H\]^−^              0.0                795.4627,633.3986,457.3314     100.00%        BR
  62    Benzoylpaeoniflorin                                     13.96        C~30~H~32~O~12~     629.1864 \[M + HCOOH-H\]^−^        1.0                165.0562,121.0307              100.00%        PRA
  63    Benzoylalbiflorin                                       14.09        C~30~H~32~O~12~     585.1967 \[M + H\]^+^              −1.0               319.1172,197.0798,133.0643     100.00%        PRA
  64    Licoricesaponin A~3~                                    14.83        C~48~H~72~O~21~     983.4493 \[M − H\]^−^              0.2                983.4633,497.1162              100.00%        GRM
  65    (+/−)−Naringenin                                        14.85        C~15~H~12~O~5~      271.0612 \[M − H\]^−^              2.7                187.0396,119.0511              100.00%        AFI
  66    4,4′-dihydroxy-2-methoxychalcone                        15.30        C~16~H~14~O~4~      269.0819 \[M − H\]^−^              4.4                269.0707,133.0297,117.0337     73.50%         GRM
  67    SSc                                                     15.79        C~48~H~78~O~17~     971.5210 \[M + HCOOH-H\]^−^        −0.7               925.5193,779.4675              100.00%        BR
  68    SSi/h                                                   15.90        C~48~H~78~O~17~     971.5209 \[M + HCOOH-H\]^−^        −0.1               925.5296, 779.4640             100.00%        BR
  69    Salicifoline                                            16.13        C~20~H~20~O~6~      355.1187 \[M − H\]^−^              −2.7               184.9549,129.0726              85.90%         BR
  70    Licoricesaponin G~2~                                    16.42        C~42~H~62~O~17~     837.3914 \[M − H\]^−^              −0.5               837.4008,351.0573,193.0347     96.60%         GRM
  71    Deacetylnomilinic acid                                  16.50        C~26~H~34~O~9~      489.2130 \[M − H\]^−^              −1.6               489.2174,333.1706,203.0687     93.20%         AFI
  72    Licoricesaponin E~2~                                    16.55        C~42~H~60~O~16~     819.3809 \[M − H\]^−^              −0.9               819.3925,351.0577,193.0343     100.00%        GRM
  73    Enoxolone                                               16.61        C~30~H~46~O~4~      471.3469 \[M + H\]^+^              0.5                471.3489,219.1769,177.1636     81.70%         GRM
  74    SSh/i                                                   16.62        C~48~H~78~O~17~     971.5210 \[M + HCOOH-H\]^−^        0.9                925.5193                       100.00%        BR
  75    Licoricesaponin D~3~                                    16.64        C~50~H~76~O~21~     1011.4806 \[M − H\]^−^             −0.9               1011.4976,497.1175             100.00%        GRM
  76    SSb~3~/b~4~                                             16.96        C~43~H~72~O~14~     857.4893 \[M + HCOOH-H\]^−^        −4.1               811.4911,649.4320,161.0409     92.40%         BR
  77    Glycyrrhizic acid                                       17.00        C~42~H~62~O~16~     823.4111 \[M + H\]^+^              0.9                647.3782,471.3467,453.3356     100.00%        GRM
  78    Isoliquiritigenin                                       17.09        C~15~H~12~O~4~      255.0663 \[M − H\]^−^              0.4                135.0074,119.0495,91.0186      100.00%        GRM
  79    Formononetin                                            17.31        C~16~H~12~O~4~      269.0808 \[M + H\]^+^              1.0                269.0811,197.0600              81.80%         GRM
  80    Acetyl-SSc                                              17.32        C~50~H~80~O~18~     1013.5316 \[M + HCOOH-H\]^−^       −2.8               967.5370,779.4628              96.60%         BR
  81    Betulonicacid                                           17.68        C~30~H~46~O~3~      455.3520 \[M + H\]^+^              0.0                455.3525,285.2216,133.1008     82.80%         GRM
  82    Palbinone                                               17.78        C~22~H~30~O~4~      357.2071 \[M − H\]^−^              −1.7               357.2067,285.1906,241.1612     92.40%         PRA
  83    SSn                                                     17.83        C~48~H~78~O~18~     987.5156 \[M + HCOOH-H\]^−^        −0.3               941.5220, 779.4644             100.00%        BR
  84    SSm/e                                                   17.94        C~42~H~68~O~12~     809.4682 \[M + HCOOH-H\]^−^        −4.8               763.4729, 617.4095, 161.0454   86.50%         BR
  85    SSa                                                     18.11        C~42~H~68~O~13~     825.4631 \[M + HCOOH-H\]^−^        2.8                779.4587, 617.4059             100.00%        BR
  86    SSb~2~                                                  18.25        C~42~H~68~O~13~     825.4631 \[M + HCOOH-H\]^−^        2.5                779.4587, 617.4059             100.00%        BR
  87    Licoricesaponin K~2~                                    18.35        C~42~H~62~O~16~     821.3965 \[M − H\]^−^              0.3                821.4084,351.0578,193.0350     72.00%         GRM
  88    Licoricesaponin H~2~                                    18.64        C~42~H~62~O~16~     821.3965 \[M − H\]^−^              −0.4               821.4067,351.0582              100.00%        GRM
  89    Limonin                                                 18.75        C~26~H~30~O~8~      469.1868 \[M − H\]^−^              −2.7               469.1872,229.1219,145.0650     90.20%         AFI
  90    2′′-*O*-Acetyl-SSa                                      18.82        C~44~H~70~O~14~     867\. 4737 \[M + HCOOH-H\]^−^      −0.3               821.4798,779.4684,617.4118     94.90%         BR
  91    Nomilinic acid                                          18.85        C~28~H~36~O~10~     531.2236 \[M − H\]^−^              −1.2               489.2170,325.1799,59.0169      100.00%        AFI
  92    Dipropyl phthalate                                      18.86        C~14~H~18~O~4~      249.1132 \[M − H\]^−^              3.0                149.0935,59.0177               85.70%         PRA
  93    Licoricesaponin J~2~                                    18.89        C~42~H~64~O~16~     823.4122 \[M − H\]^−^              0.1                823.4212,351.0575,193.0352     100.00%        GRM
  94    SSg                                                     18.98        C~42~H~68~O~13~     825.4631 \[M + HCOOH-H\]^−^        1.3                779.4665,617.4099              100.00%        BR
  95    Nobiletin                                               19.04        C~21~H~22~O~8~      403.1387 \[M + H\]^+^              1.1                403.1383,373.0912,327.0860     77.80%         AFI
  96    SSb~1~                                                  19.05        C~42~H~68~O~13~     825.4631 \[M + HCOOH-H\]^−^        1.1                779.4587,617.4059              100.00%        BR
  97    3′′-*O*-Acetyl-SSa                                      19.13        C~44~H~70~O~14~     867\. 4737 \[M + HCOOH-H\]^−^      0.2                821.4781,779.4662,617.4096     100.00%        BR
  98    4′′-*O*-Acetyl-SSa                                      19.28        C~44~H~70~O~14~     867\. 4737 \[M + HCOOH-H\]^−^      −0.7               821.4775,779.4658,617.4094     100.00%        BR
  99    Licoricesaponin C~2~                                    19.44        C~42~H~62~O~15~     805.4016 \[M − H\]^−^              0.1                805.4118,351.0568              100.00%        GRM
  100   prosaikogenin f                                         19.49        C~36~H~58~O~8~      663.4103 \[M + HCOOH-H\]^−^        −0.6               617.4094,145.0499              77.80%         BR
  101   SSe/m                                                   19.59        C~42~H~68~O~12~     809.4682 \[M + HCOOH-H\]^−^        −1.3               763.4722,601.4170,161.0442     96.40%         BR
  102   Licoricesaponin B~2~                                    19.72        C~42~H~64~O~15~     807.4173 \[M − H\]^−^              −0.6               807.4277,351.0574,193.0343     100.00%        GRM
  103   6′′-*O*-Acetyl-SSa                                      20.09        C~44~H~70~O~14~     867\. 4737 \[M + HCOOH-H\]^−^      −0.2               821.4780,779.4666,617.4095     100.00%        BR
  104   Licoisoflavone a                                        20.27        C~20~H~18~O~6~      353.1031 \[M − H\]^−^              2.4                353.1056,285.1131,171.0446     74.90%         GRM
  105   Glycycoumarin                                           20.40        C~21~H~20~O~6~      367.1187 \[M − H\]^−^              0.5                367.1188,309.0411,201.0187     89.90%         GRM
  106   Prosaikogenin g                                         20.56        C~36~H~58~O~8~      663.4103 \[M + HCOOH-H\]^−^        −0.1               617.4060,145.0540              100.00%        BR
  107   SSd                                                     20.61        C~42~H~68~O~13~     825.4631 \[M + HCOOH-H\]^−^        2.5                779.4587,617.4059              100.00%        BR
  108   Sinensitin                                              20.66        C~20~H~20~O~7~      373.1282 \[M + H\]^+^              1.1                373.1288,297.0766              79.80%         AFI
  109   Diacetyl-SSd                                            21.03        C~46~H~72~O~15~     909.4823 \[M + HCOOH-H\]^−^        −0.7               863.4894,821.4782,761.4554     92.00%         BR
  110   2′′-*O*-Acetyl-SSd                                      21.04        C~44~H~70~O~14~     867\. 4737 \[M + HCOOH-H\]^−^      −0.4               821.4766,779.4660,617.4085     100.00%        BR
  111   Liconeolignan                                           21.33        C~21~H~22~O~5~      354.1467 \[M − H\]^−^              −1.9               353.1020,297.0441,173.0224     80.30%         GRM
  112   Diacetyl-SSd                                            21.61        C~46~H~72~O~15~     909.4823 \[M + HCOOH-H\]^−^        0.0                863.4896,821.4773,761.4552     100.00%        BR
  113   3′′-*O*-Acetyl-SSd                                      21.89        C~44~H~70~O~14~     867\. 4737 \[M + HCOOH-H\]^−^      0.3                821.4794,779.4683,617.4103     100.00%        BR
  114   Acetyl-SSe                                              21.95        C~44~H~70~O~13~     851.4788 \[M + HCOOH-H\]^−^        −1.7               805.4838,763.4701,601.4155     91.00%         BR
  115   Neoglycyrol                                             22.36        C~21~H~18~O~6~      365.1031 \[M − H\]^−^              0.3                365.1037,307.0250,207.0430     96.40%         GRM
  116   Prosaikogenin d                                         22.42        C~36~H~58~O~8~      663.4103 \[M + HCOOH-H\]^−^        −1.9               617.408                        72.80%         BR
  117   6′′-*O*-Acetyl-SSd                                      22.54        C~44~H~70~O~14~     867\. 4737 \[M + HCOOH-H\]^−^      −0.9               821.4770,779.4651,617.4087     100.00%        BR
  118   Obacunon                                                22.74        C~26~H~30~O~7~      453.1919 \[M − H\]^−^              −4.2               453.2044,339.1957,149.0963     90.20%         AFI
  119   Saikogenin e                                            22.78        C~30~H~48~O~3~      455.3519 \[M − H\]^−^              −2.5               455.3529, 325.1855, 152.9936   93.20%         BR
  120   Diacetyl-SSd                                            23.06        C~46~H~72~O~15~     909.4823 \[M + HCOOH-H\]^−^        −3.0               863.4894,821.4774,617.4091     100.00%        BR
  121   Diacetyl-SSd                                            23.24        C~46~H~72~O~15~     909.4823 \[M + HCOOH-H\]^−^        −2.7               863.4859,821.4747,761.4478     94.40%         BR
  122   Saikogenin f                                            23.38        C~30~H~48~O~4~      533.3473 \[M + HCOOH-H\]^−^        −6.3               471.3452,453.1727,388.9749     90.10%         BR

molecules-23-03128-t002_Table 2

###### 

Results of the *t*-test of 26 peaks from BR showing significant difference in individual herb, herb-pair, and complicated Chinese herbal formula before and after processing (*n* = 6).

  BR    Individual Herb   Herb-Pair                   Herbal Formula                                
  ----- ----------------- --------------------------- ---------------------- ---------------------- ----------------------
  1     0.82              Adonitol                    0.00394 ↓ \*\*         0.00011 ↓ \*\*         [  ]{.ul}
  11    4.18              Chlorogenic acid            0.00137 ↓ \*\*         [  ]{.ul}              [  ]{.ul}
  27    7.57              Rutin                       0.00946 ↓ \*\*         [  ]{.ul}              [  ]{.ul}
  35    9.56              Isorhamnetin                0.04005 ↑ \*           [  ]{.ul}              0.01029 ↑ \*
  36    9.65              Isorhamnetin-3-rutinoside   [  ]{.ul}              0.00055 ↓ \*\*         [  ]{.ul}
  59    12.79             HOSSd                       [  ]{.ul}              0.00077 ↓ \*\*         [  ]{.ul}
  60    13.24             Buddlejasaponin IV          1.72 × 10^−5^ ↓ \*\*   [  ]{.ul}              3.90 × 10^−6^ ↓ \*\*
  67    15.79             SSc                         0.01180 ↓ \*           [  ]{.ul}              [  ]{.ul}
  68    15.9              SSi/h                       0.00130 ↑ \*\*         3.34 × 10^−8^ ↑ \*\*   [  ]{.ul}
  74    16.62             SSh/i                       0.00017 ↑ \*\*         0.00027 ↑ \*\*         [  ]{.ul}
  80    17.32             AcetylSSc                   0.00089 ↓ \*\*         [  ]{.ul}              0.01867 ↓ \*
  85    18.11             SSa                         0.00475 ↓ \*\*         [  ]{.ul}              [  ]{.ul}
  86    18.25             SSb~2~                      0.03997 ↑ \*           [  ]{.ul}              [  ]{.ul}
  94    18.98             SSg                         0.00577 ↑ \*\*         1.90 × 10^−6^ ↑ \*\*   0.04480 ↑ \*
  96    19.05             SSb~1~                      0.00656 ↑ \*\*         4.85 × 10^−5^ ↑ \*\*   [  ]{.ul}
  97    19.13             3′′-*O*-AcetylSSa           0.00016 ↑ \*\*         4.18 × 10^−6^ ↑ \*\*   0.002821 ↑ \*\*
  98    19.28             4′′-*O*-AcetylSSa           [  ]{.ul}              [  ]{.ul}              0.001645 ↑ \*\*
  100   19.49             prosaikogenin f             0.00031 ↓ \*\*         0.00281 ↑ \*\*         [  ]{.ul}
  101   19.59             SSe/m                       0.00014 ↓ \*\*         [  ]{.ul}              0.00626 ↓ \*\*
  103   20.09             6′′-*O*-AcetylSSa           4.43 × 10^5^ ↓ \*\*    [  ]{.ul}              0.024542 ↓ \*
  107   20.61             SSd                         0.00299 ↓ \*\*         0.00078 ↓ \*\*         0.04567 ↓ \*
  110   21.04             2′′-*O*-AcetylSSd           [  ]{.ul}              0.00116 ↓ \*\*         [  ]{.ul}
  112   21.61             Diacetyl-SSd                0.03744 ↓ \*           [  ]{.ul}              [  ]{.ul}
  113   21.89             3′′-*O*-AcetylSSd           9.31 × 10^−7^ ↓ \*\*   [  ]{.ul}              [  ]{.ul}
  117   22.54             6′′-*O*-AcetylSSd           0.00053 ↓ \*\*         [  ]{.ul}              0.04310 ↓ \*
  121   23.24             Diacetyl-SSd                1.06 × 10^−8^ ↓ \*\*   [  ]{.ul}              [  ]{.ul}

Compared with BR, "↓" represents decrease in contents, "↑" represents increase in contents, \* *p* \< 0.05, \*\* *p* \< 0.01.

molecules-23-03128-t003_Table 3

###### 

Results of *t*-test of 22 peaks from PRA showing significant difference in individual herb, herb-pair, and complicated Chinese herbal formula before and after processing (*n* = 6).

  PRA   Individual Herb   Herb-Pair                                               Herbal Formula                                 
  ----- ----------------- ------------------------------------------------------- ----------------------- ---------------------- ----------------------
  2     0.83              Sucrose                                                 0.00678 ↓ \*\*          0.00852 ↓ \*\*         [  ]{.ul}
  4     1.97              Gallic acid                                             0.00250 ↓ \*\*          [  ]{.ul}              [  ]{.ul}
  5     2.39              1-*O*-β-[d]{.smallcaps}-glucopyranosyl-paeonisuffrone   0.02508 ↑ \*            0.04461 ↑ \*           [  ]{.ul}
  6     3.16              6-*O*-β-[d]{.smallcaps}-glucopyranosyl lactinolide      [  ]{.ul}               0.03649 ↑ \*           4.15 × 10^−5^ ↑ \*\*
  7     3.31              Mudanpioside f                                          0.00056 ↑ \*\*          0.04576 ↑ \*           0.00043 ↑ \*\*
  9     3.83              Oxypaeoniflora                                          2.79 × 10^−6^ ↑ \*\*    [  ]{.ul}              0.00021 ↑ \*\*
  10    4.16              4′′-Hydroxy-3′′-methoxyalbiflorin                       0.04610 ↑ \*            [  ]{.ul}              [  ]{.ul}
  13    4.40              Cianidanol                                              0.01515 ↑ \*            0.00631 ↓ \*\*         [  ]{.ul}
  15    4.76              6′-*O*-β-[d]{.smallcaps}-glucopyranosylalbiflorin       0.02004 ↓ \*            [  ]{.ul}              0.04757 ↓ \*
  18    5.13              Isomaltopaeoniflorin                                    1.28 × 10^−9^ ↓ \*\*    2.58 × 10^−6^ ↓ \*\*   [  ]{.ul}
  19    5.49              Albiflorin                                              7.64 × 10^−8^ ↑ \*\*    0.00303 ↑ \*\*         0.01407 ↑ \*
  20    5.58              Paeoniflorigenone                                       8.60 × 10^−10^ ↑ \*\*   0.02864 ↑ \*           0.0168 ↑ \*
  21    5.61              Isomaltoalbiflorin                                      0.00062 ↑ \*\*          0.00952 ↑ \*\*         0.040769 ↑ \*
  23    5.98              Paeoniflorin                                            0.04235 ↓ \*            [  ]{.ul}              [  ]{.ul}
  24    6.70              Paeonol                                                 2.80 × 10^−7^ ↑ \*\*    0.00106 ↑ \*\*         0.00418 ↑ \*\*
  39    10.08             Benzoic acid                                            5.34 × 10^−5^ ↓ \*\*    0.00558 ↓ \*\*         0.04072 ↓ \*
  41    10.18             Mudanpioside i                                          0.00050 ↑ \*\*          [  ]{.ul}              [  ]{.ul}
  42    10.19             Galloylpaeoniflorin                                     0.00260 ↓ \*\*          [  ]{.ul}              0.00856 ↑ \*\*
  48    10.68             Lactiflorin                                             0.03681 ↑ \*            [  ]{.ul}              0.00508 ↓ \*\*
  62    13.96             Benzoylpaeoniflorin                                     [  ]{.ul}               0.00078 ↑ \*\*         [  ]{.ul}
  63    14.09             Benzoylalbiflorin                                       2.40 × 10^−5^ ↑ \*\*    [  ]{.ul}              0.02116 ↑ \*
  82    17.78             Palbinone                                               1.72 × 10^−6^ ↑ \*\*    [  ]{.ul}              [  ]{.ul}

Compared with PRA, "↓" represents decrease in contents, "↑" represents increase in contents, \* *p* \< 0.05, \*\* *p* \< 0.01.
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###### 

Results of *t*-test of 12 peaks from AFI and GRM showing significant difference (*n* = 6).

  No.   T~R~ (min)   Identified Compound                    *t*-Value   *p*-Value              Source
  ----- ------------ -------------------------------------- ----------- ---------------------- --------
  17    4.99         Lonicerin                              2.44        0.03474 ↑ \*           AFI
  22    5.91         Schaftoside                            −4.17       0.00193 ↓ \*\*         AFI
  29    7.93         Liquiritin                             8.36        8.02 × 10^−6^ ↑ \*\*   GRM
  44    10.39        Hesperetin                             −4.07       0.00361 ↓ \*\*         AFI
  49    10.83        Ononin                                 5.62        0.00050 ↑ \*\*         GRM
  58    12.65        5,4′′-dihydroxy-3,7-dimethoxyflavone   −2.31       0.04979 ↓ \*           GRM
  64    14.83        Licoricesaponin A~3~                   −4.69       0.00085 ↓ \*\*         GRM
  70    16.42        Licoricesaponin G~2~                   −3.40       0.00677 ↓ \*\*         GRM
  72    16.55        Licoricesaponin E~2~                   3.53        0.00548 ↑ \*\*         GRM
  79    17.31        Formononetin                           −3.28       0.01125 ↓ \*           GRM
  104   20.27        Licoisoflavone a                       −4.16       0.00195 ↓ \*\*         GRM
  105   20.40        Glycycoumarin                          5.93        0.00014 ↑ \*\*         GRM

Compared with SNS, "↓" represents decrease in contents, "↑" represents increase in contents, \* *p* \< 0.05, \*\* *p* \< 0.01.

[^1]: These authors contributed equally to this work.
